|
Information
about the speakers
Dr.
François Chrétien
Patent
specialist for Rhône Poulenc Agro. He is represented
in the FEBC Policy Group on legal protection for biotech
inventions. He demonstrates the experience of a European
company with patents in the field of plant breeding
and the need for protecting research efforts and the
influence of these developments on research, dissemination
of research results, and the structure of the industry.
Ms.
Lisbet Dyerberg
Master
of Law at the Danish Patent Office. At the legal department
her main fields of activity are patents. Apart from
the EU patent directive for bio-technological inventions,
this includes e.g. the European Commission’s green
paper on patents, the EU patent system and other international
patent aspects. She was closely involved in the work
relating to the Danish acceptance of the directive and
will be working on the implementation of the EU directive
to Danish law.
Dr.
Harry Griffin
Assistant
director (science) of Roslin Institute, Midlothian,
UK. Roslin Institute is a leading international Centre
for research on molecular and quantitative genetics
of farm animals. It also has important programmes on
early embryology, reproduction, growth, poultry science,
nutrition and animal welfare.
It's research
on nuclear transfer led firstly to the production of
lambs from embryo-derived cells and then to the birth
of 'Dolly' the sheep, the world's first mammal cloned
from an adult cell.
Dr.
Hans-Rainer Jaenichen, Dipl.-Biol.
Specialist
for biotechnological inventions at Vossius & Partner,
a law firm in Munich, Germany, having Patentanwälte,
European Patent Attorneys and European Trademark Attorneys.
He explains the procedure and costs for getting a European
patent. The information is valuable and practical for
scientists and/or companies who seek to protect their
research results as intellectual property.
Mr.
Ed Kenney
Director
of Innovations Foundation (IF) in Toronto, Canada. The
Foundation is the owner of the halothane gene patent
for stress resistance in pigs (Maligne Hyperthermie).
This patent is widely known in the animal production
world. It illustrates the scope of the directive in
a practical case. Patents and the protection of inventions
are a rather new area for scientists and companies in
the field of animal breeding and reproduction.
Mr.
Willi Rothley, Mr. Armin Machmer
Mr. Willi
Rothley: Member of European Parliament (MEP) for the
Party of European Socialists (PSE), rapporteur for the
Legal Affairs Committee of the European Parliament.
The Legal Affairs Committee is the committee responsible
for the new European patent directive for biotechnological
inventions. Mr. Armin Machmer: political advisor to
the Socialist Group of the Committee on Research and
Technology in European Parliament. In the absence of
Rothley he has made the presentation on his behalf.
Before that he worked as an independent lawyer, as a
research assistant for Mrs. Roth-Behrendt MEP, and for
CEC DGIII.
Professor
Peter Sandøe
Research
professor in bio-ethics at the Veterinary and Agricultural
University, Department of Animal Science and Animal
Health of Copenhagen, Denmark. Philosopher, educated
at the universities of Copenhagen and Oxford. Since
1992 Chairman of the Danish Ethical Council for Animals.
Research in Bioethics with particular emphasis on the
ethical issues related to animals and biotechnology.
Dr.
Nick Scott-Ram
Chairman
of the UK BioIndustry Association's Intellectual Property
Advisory Committee and EuropaBio's Patents Task Force.
He was, until recently, with British Biotech and is
now building up his own consultancy business with a
particular focus on start-ups. He has been chairing
the policy group on the legal protection of biotech
inventions of the Forum for European Bioindustry Coordination
(FEBC). The secretariat is provided by EuropaBio, the
European Association for Bioindustries. FEBC is an informal
grouping of the major Bio-Industries in Europe.
|
